Search results for "COVID-19"
New COVID-19 vaccine recommendations, data on after-effects of infection
The CDC recommended another COVID-19 booster for older patients and ended five-day isolation guidelines, while studies showed that COVID-19 infection was associated with a small cognitive decline and an increase in risk for autoimmune inflammatory rheumatic diseases.
https://immattersacp.org/weekly/archives/2024/03/05/4.htm
5 Mar 2024
When to test, isolate, prescribe for outpatient COVID-19
Panelists at ACP and Annals of Internal Medicine's eighth virtual forum on COVID-19 discussed the latest recommendations and treatment options.
https://immattersacp.org/archives/2022/03/when-to-test-isolate-prescribe-for-outpatient-covid-19.htm
1 Mar 2022
One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound
A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023
Busting COVID-19 vaccination myths
Misinformation and disinformation campaigns have contributed to the death toll of the COVID-19 pandemic. Internists can effectively counter this and encourage vaccinations.
https://immattersacp.org/archives/2021/11/busting-covid-19-vaccination-myths.htm
1 Nov 2021
CDC publishes guidance on testing for flu, COVID-19
Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023
Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions
Viral load of SARS-CoV-2 doesn't peak until the fourth day of symptoms, one study found, while other research only saw an effect of nirmatrelvir/ritonavir on death and hospitalization among those who were moderately or severely immunocompromised, not in other high-risk groups.
https://immattersacp.org/weekly/archives/2023/10/03/2.htm
3 Oct 2023
Get with the latest ARDS guideline
Experts tasked with updating guidelines on acute respiratory distress syndrome (ARDS) found a lot of new data to incorporate.
https://immattersacp.org/archives/2024/03/get-with-the-latest-ards-guideline.htm
1 Mar 2024
CDC recommends COVID-19 booster; ACP updates practice points for outpatient treatment
Everyone ages 6 months and older should get an updated COVID-19 vaccine to protect against a potentially serious outbreak this fall and winter, the CDC said last week.
https://immattersacp.org/weekly/archives/2023/09/19/1.htm
19 Sep 2023
New findings on antiviral flu treatment
A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023
Coadministration of zoster vaccine, COVID-19 booster appears safe, effective
An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023